Cargando…

Clinical Impact of Minimal Residual Disease in Children with Different Subtypes of Acute Lymphoblastic Leukemia Treated with Response-Adapted Therapy

To determine the clinical significance of minimal residual disease (MRD) in patients with prognostically relevant subtypes of childhood acute lymphoblastic leukemia (ALL), we analyzed data from 488 patients treated in St. Jude Total Therapy Study XV with treatment intensity based mainly on MRD level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pui, Ching-Hon, Pei, Deqing, Raimondi, Susana C, Coustan-Smith, Elaine, Jeha, Sima, Cheng, Cheng, Bowman, W Paul, Sandlund, John T, Ribeiro, Raul C, Rubnitz, Jeffrey E, Inaba, Hiroto, Gruber, Tanja A, Leung, Wing H, Yang, Jun J, Downing, James R, Evans, William E, Relling, Mary V, Campana, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288281/ https://www.ncbi.nlm.nih.gov/pubmed/27560110 http://dx.doi.org/10.1038/leu.2016.234

Ejemplares similares

A Revised Definition for Cure of Childhood Acute Lymphoblastic Leukemia
por: Pui, CH, et al.
Publicado: (2014)

Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16
por: Gruber, Tanja A., et al.
Publicado: (2022)

Long-term results of St. Jude Total Therapy studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia
por: Pui, C-H, et al.
Publicado: (2009)

Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy
por: Karol, Seth E., et al.
Publicado: (2021)

Erratum to: Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments
por: Pauley, Jennifer L., et al.
Publicado: (2013)

Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments
por: Pauley, Jennifer L., et al.
Publicado: (2013)

Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia
por: Karol, Seth E., et al.
Publicado: (2023)

The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia
por: Eissa, H M, et al.
Publicado: (2017)

Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia
por: Inaba, Hiroto, et al.
Publicado: (2021)

Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies
por: Robinson, Katherine M., et al.
Publicado: (2018)

Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia
por: Ramsey, Laura B., et al.
Publicado: (2015)

Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response
por: Lee, Shawn H. R., et al.
Publicado: (2023)

1155. Covering Your Tracts? The Effect of Antibiotic Prophylaxis on Respiratory Tract Infections in Pediatric Acute Lymphoblastic Leukemia
por: Strength, Rachel, et al.
Publicado: (2021)

Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment
por: Bhattarai, Kashi Raj, et al.
Publicado: (2023)

In Vivo Response to Methotrexate Forecasts Outcome of Acute Lymphoblastic Leukemia and Has a Distinct Gene Expression Profile
por: Sorich, Michael J, et al.
Publicado: (2008)

Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architectures
por: Barnett, Kelly R., et al.
Publicado: (2023)

Germline Genetic NBN Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in Children
por: Escherich, Carolin, et al.
Publicado: (2023)

Vaccines against SARS‐CoV‐2 are safe to administer in patients with antibodies to pegaspargase
por: Swanson, Hope D., et al.
Publicado: (2022)

Modeling Mechanisms of In Vivo Variability in Methotrexate Accumulation and Folate Pathway Inhibition in Acute Lymphoblastic Leukemia Cells
por: Panetta, John C., et al.
Publicado: (2010)

Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia
por: Karol, Seth E., et al.
Publicado: (2017)

Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia
por: Karol, Seth E., et al.
Publicado: (2020)

DNA Methylation Clusters and Their Relation to Cytogenetic Features in Pediatric AML
por: Lamba, Jatinder K., et al.
Publicado: (2020)

Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia
por: Ferguson, Daniel C., et al.
Publicado: (2022)

Combination of Cladribine and Cytarabine is Effective for Childhood Acute Myeloid Leukemia: Results of the St. Jude AML97 Trial
por: Rubnitz, Jeffrey E., et al.
Publicado: (2009)

Antibiotic prophylaxis and the gastrointestinal resistome in paediatric patients with acute lymphoblastic leukaemia: a cohort study with metagenomic sequencing analysis
por: Margolis, Elisa B, et al.
Publicado: (2021)

Population PK/PD Model of Homocysteine Concentrations after High-Dose Methotrexate Treatment in Patients with Acute Lymphoblastic Leukemia
por: Rühs, Hauke, et al.
Publicado: (2012)

Measurements of treatment response in childhood acute leukemia
por: Campana, Dario, et al.
Publicado: (2012)

Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia
por: Kamens, Jennifer L., et al.
Publicado: (2023)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Precision medicine in acute lymphoblastic leukemia
por: Pui, Ching-Hon
Publicado: (2020)

Correction: Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia
por: Lamba, Jatinder K., et al.
Publicado: (2018)

Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia
por: Lamba, Jatinder K., et al.
Publicado: (2018)

Author Correction: Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia
por: Kamens, Jennifer L., et al.
Publicado: (2023)

Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia
por: Bergeron, Brennan P., et al.
Publicado: (2023)

Changes in body mass index, weight, and height in children with acute myeloid leukemia and the associations with outcome
por: Iijima, Mayuko, et al.
Publicado: (2022)

Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia Cells
por: Rowland, Lauren, et al.
Publicado: (2023)

A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
por: Nguyen, Rosa, et al.
Publicado: (2019)

The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias
por: Andersson, Anna K, et al.
Publicado: (2015)

S107: IDENTIFICATION AND CHARACTERIZATION OF GERMLINE NBN VARIANTS RELATED TO B-ALL PREDISPOSITION
por: Escherich, Carolin, et al.
Publicado: (2023)

Simultaneous monitoring of disease and microbe dynamics through plasma DNA sequencing in pediatric patients with acute lymphoblastic leukemia
por: Barsan, Valentin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u510t3bcdfet6u6s374ii5en3i